Fundraising Fox

Nitrome Biosciences

Jackson, US · Delaware corporation · 3 known investors

Biotech

Founders & leadership

IG
Irene Griswold-PrennerFounder

Board

ZH
Zach HallBoard director
EH
Ephraim HellerBoard director
WM
William McDowellBoard director
RK
Regis KellyBoard director

Investors · 3

SV Health InvestorsBoston · $1M – $20M
Dementia Discovery FundreportedLondon
Sofinnova PartnersreportedParis · $540K – $27M

Reported raises · per SEC filings

Form D private placements

$18.9M disclosed across 5 rounds · 2018–2020

▶$17.1MraisedApr 2020 · 18 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Margarita ChavezDirector
  • Irene Griswold-PrennerExecutive Officer, Director
  • Henrijette RichterDirector
  • Jonathan BehrDirector
Offering amount
$47.5M
Amount sold
$17.1M
First sale
Apr 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$500KraisedJul 2019 · 9 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Zach HallDirector
  • Ephraim HellerDirector
  • William McDowellDirector
  • Irene Griswold-PrennerExecutive Officer, Director
  • Regis KellyDirector
Offering amount
$500K
Amount sold
$500K
First sale
Jun 2019
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$400KraisedJan 2019 · 8 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Regis KellyDirector
  • Irene Griswold-PrennerExecutive Officer, Director
  • Zach W. HallDirector
  • William McDowellDirector
  • Ephraim HellerDirector
Offering amount
$1.6M
Amount sold
$400K
Minimum investment
$10K
Proceeds to insiders
$14.5K
First sale
Dec 2018
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$750KraisedJul 2018 · 5 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Irene Griswold-PrennerExecutive Officer
Offering amount
$2.4M
Amount sold
$750K
Minimum investment
$10K
Proceeds to insiders
$250K
First sale
Jun 2018
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$104.6KraisedJul 2018 · 5 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Regis KellyDirector
  • Ephreim HellerDirector
  • Zach W. HallDirector
  • Irene Griswold-PrennerExecutive Officer, Director
Offering amount
$104.6K
Amount sold
$104.6K
Minimum investment
$900
First sale
Feb 2018
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Nitrase Therapeutics Announces Presentation at the SFN Neuroscience 2023 Annual Meetingfinance.yahoo.com · Nov 2023Nitrome Biosciences Raises $38M Series A Financing - MBC BioLabsmbcbiolabs.com · May 2020Nitrome Raises $38M to Begin Tests of Potential Parkinson's Treatmentparkinsonsnewstoday.com · Apr 2020Nitrome Biosciences Raises $38M Series A Financing to Advance Therapeutics Targeting a Novel Group of Enzymes involved in Age-related Diseasesbusinesswire.com · Apr 2020Discovering Biotech Startups: A map for Selling to Nitrome Biosciencesblog.zymewire.com · Mar 2020The state of medical research in Wyoming | Special | wyomingnews.comwyomingnews.com · Nov 2019

Frequently asked questions

Who founded Nitrome Biosciences?
Nitrome Biosciences was founded by Irene Griswold-Prenner.
Who are Nitrome Biosciences's investors?
Nitrome Biosciences's investors include SV Health Investors, Dementia Discovery Fund, Sofinnova Partners.
How much funding has Nitrome Biosciences raised?
Nitrome Biosciences has disclosed $18.9M raised across 5 rounds.
Where is Nitrome Biosciences headquartered?
Nitrome Biosciences is headquartered in Jackson, US.